David K. Glover
Cardiovascular Division
Department of Medicine
University of Virginia Health System
Charlottesville
USA
Name/email consistency: high
- Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia. Glover, D.K., Ruiz, M., Takehana, K., Petruzella, F.D., Rieger, J.M., Macdonald, T.L., Watson, D.D., Linden, J., Beller, G.A. Am. J. Physiol. Heart Circ. Physiol. (2007)
- Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium. Glover, D.K., Riou, L.M., Ruiz, M., Sullivan, G.W., Linden, J., Rieger, J.M., Macdonald, T.L., Watson, D.D., Beller, G.A. Am. J. Physiol. Heart Circ. Physiol. (2005)
- Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection. Glover, D.K., Ruiz, M., Takehana, K., Petruzella, F.D., Riou, L.M., Rieger, J.M., Macdonald, T.L., Watson, D.D., Linden, J., Beller, G.A. Circulation (2001)
- Myocardial 99mTc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis: comparison with 201Tl and regional myocardial blood flow. Glover, D.K., Ruiz, M., Yang, J.Y., Smith, W.H., Watson, D.D., Beller, G.A. Circulation (1997)